http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20090029735-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_adb0e564374fedf34b36103d36e6455a
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-166
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L2-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K20-111
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-352
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-357
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-357
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-00
filingDate 2007-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24866e4a612b1dfaf2266c8000885e7f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8e23223edc889ab338fa6a116baf91f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8776bcbecb09ada02c2ab60cdfb8ed60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65efcd245b38a7db746508f8560a9b31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a1e9c51f1b28e816d87dc8cfd53f381
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9795acc304a285685eca1cab0399af8
publicationDate 2009-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20090029735-A
titleOfInvention Treatment of muscle diseases and improvement of muscle function
abstract The present invention relates to the compounds of formulas (la) It is about. Other fields of use include diseases associated with lipid metabolism failure, glucose metabolism failure and insulin dysfunction, obesity, overweight, eating disorders such as bulimia and anorexia, cardiovascular disease, atherosclerosis, vascular disease, heart failure, inflammatory disease For example, arthritis, rheumatoid arthritis, osteoarthritis, gout, gastrointestinal diseases, such as inflammatory bowel syndrome, Crohn's disease, gastritis, irritable bowel syndrome and ulcerative colitis, skin related diseases such as psoriasis, eczema, Burns, dermatitis and allergies, breathing disorders such as asthma, chronic obstructive pulmonary disease (COPD), allergic diseases, and / or bone diseases such as osteoporosis and osteopenia. The compounds may also be used for body correction, for improving the muscle to fat ratio, or for facilitating skin wound healing. The present invention also contains (enhanced) foods, beverages, (enhanced) feeds, food additives, beverage additives, feed additives, clinical nutritional supplements, dietary supplements, functional foods, functional feeds and dietary supplements, and the compounds Pharmaceutical compositions, methods of treating the aforementioned diseases / diseases in mammals, including humans, and the compounds of formula (I) themselves. Another object of the present invention is the use of said compound for preparing a composition for treating said disease / disease as described above.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020027586-A1
priorityDate 2006-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466583715

Total number of triples: 52.